Two-thirds of mupirocin-resistant MRSA wrongly treated
Two-thirds of patients with high-level mupirocin-resistant, methicillin-resistant Staphylococcus aureus are receiving the wrong treatment because of an inefficient process for reporting sensitivity results. The findings highlight the widespread need for electronic, integrated systems to improve appropriate and timely prescribing and to prevent development of nosocomial MRSA infections, along with the further development of resistance, according to a study.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063